Search research articles
Contact Us
Filters
Showing results (61-70 of 325) with videos related to
Page
of 33
Sort By:
Peptides
|
February 26, 2026
Long-acting amylin-related peptides as therapies for obesity and type 2 diabetes
Clifford J Bailey, Peter R Flatt, J Michael Conlon
Biochemical and Biophysical Research Communications
|
August 7, 2003
Glucose-dependent insulinotropic polypeptide analogues and their therapeutic potential for the treatment of obesity-diabetes
Victor A Gault, Peter R Flatt, Finbarr P M O'Harte
Diabetes/Metabolism Research and Reviews
|
September 27, 2014
Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes
Rachel Charlotte Moffett, Steven Patterson, Nigel Irwin, et al.
The British Journal of Nutrition
|
September 3, 2009
Terminalia bellirica stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro
Violet Kasabri, Peter R Flatt, Yasser H A Abdel-Wahab
Metabolism: Clinical and Experimental
|
August 11, 2020
Generation and characterisation of C-terminally stabilised PYY molecules with potential in vivo NPYR2 activity
Ryan A Lafferty, Neil Tanday, Peter R Flatt, et al.
Experimental Gerontology
|
December 23, 2006
Beneficial effects of sub-chronic activation of glucagon-like peptide-1 (GLP-1) receptors on deterioration of glucose homeostasis and insulin secretion in aging mice
Nigel Irwin, Paula L McClean, Patrick Harriott, et al.
Biochemical Pharmacology
|
May 4, 2020
Dapagliflozin exerts positive effects on beta cells, decreases glucagon and does not alter beta- to alpha-cell transdifferentiation in mouse models of diabetes and insulin resistance
Neil Tanday, Nigel Irwin, Peter R Flatt, et al.
European Journal of Pharmacology
|
November 18, 2009
Insulin-releasing and metabolic effects of small molecule GLP-1 receptor agonist 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline
Nigel Irwin, Peter R Flatt, Steven Patterson, et al.
The British Journal of Nutrition
|
March 4, 2006
Asparagus adscendens (Shweta musali) stimulates insulin secretion, insulin action and inhibits starch digestion
Jacqueline N Mathews, Peter R Flatt, Yasser H Abdel-Wahab
Peptides
|
February 8, 2018
Role of islet peptides in beta cell regulation and type 2 diabetes therapy
Dawood Khan, Charlotte R Moffet, Peter R Flatt, et al.
Page
of 33
Search research articles
Search
Showing results (61-70 of 325) with videos related to
Sort By:
Page
of 33
Peptides
|
February 26, 2026
Long-acting amylin-related peptides as therapies for obesity and type 2 diabetes
Clifford J Bailey, Peter R Flatt, J Michael Conlon
Biochemical and Biophysical Research Communications
|
August 7, 2003
Glucose-dependent insulinotropic polypeptide analogues and their therapeutic potential for the treatment of obesity-diabetes
Victor A Gault, Peter R Flatt, Finbarr P M O'Harte
Diabetes/Metabolism Research and Reviews
|
September 27, 2014
Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes
Rachel Charlotte Moffett, Steven Patterson, Nigel Irwin, et al.
The British Journal of Nutrition
|
September 3, 2009
Terminalia bellirica stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro
Violet Kasabri, Peter R Flatt, Yasser H A Abdel-Wahab
Metabolism: Clinical and Experimental
|
August 11, 2020
Generation and characterisation of C-terminally stabilised PYY molecules with potential in vivo NPYR2 activity
Ryan A Lafferty, Neil Tanday, Peter R Flatt, et al.
Experimental Gerontology
|
December 23, 2006
Beneficial effects of sub-chronic activation of glucagon-like peptide-1 (GLP-1) receptors on deterioration of glucose homeostasis and insulin secretion in aging mice
Nigel Irwin, Paula L McClean, Patrick Harriott, et al.
Biochemical Pharmacology
|
May 4, 2020
Dapagliflozin exerts positive effects on beta cells, decreases glucagon and does not alter beta- to alpha-cell transdifferentiation in mouse models of diabetes and insulin resistance
Neil Tanday, Nigel Irwin, Peter R Flatt, et al.
European Journal of Pharmacology
|
November 18, 2009
Insulin-releasing and metabolic effects of small molecule GLP-1 receptor agonist 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline
Nigel Irwin, Peter R Flatt, Steven Patterson, et al.
The British Journal of Nutrition
|
March 4, 2006
Asparagus adscendens (Shweta musali) stimulates insulin secretion, insulin action and inhibits starch digestion
Jacqueline N Mathews, Peter R Flatt, Yasser H Abdel-Wahab
Peptides
|
February 8, 2018
Role of islet peptides in beta cell regulation and type 2 diabetes therapy
Dawood Khan, Charlotte R Moffet, Peter R Flatt, et al.
Page
of 33